Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

OHSU researchers discovered a new blood test that identifies pancreatic cancer early on with 85% accuracy when done alongside the current CA 19-9 test.

The assay showed improved detection of early-stage cancer when combined with carbohydrate antigen 19-9 (CA 19-9). CA 19-9, the only Food and Drug Administration–approved biomarker for PDAC ...